Dataset Information
Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study.
Ontology highlight
ABSTRACT: Background
Increasing data suggest that aspirin use may improve cancer survival; however, the evidence is sparse for ovarian cancer.Methods
We examined the association between postdiagnosis use of low-dose aspirin and mortality in a nationwide cohort of women with epithelial ovarian cancer between 2000 and 2012. Information on filled prescriptions of low-dose aspirin, dates and causes of death, and potential confounding factors was obtained from nationwide Danish registries. We used Cox regression models to estimate hazard ratios (HRs) with 95% confidence intervals (CIs) for ovarian cancer-specific or other-cause mortality associated with low-dose aspirin use.Results
Among 4117 patients, postdiagnosis use of low-dose aspirin was associated with HRs of 1.02 (95% CI: 0.87-1.20) for ovarian cancer mortality and 1.06 (95% CI: 0.77-1.47) for other-cause mortality. Hazard ratios remained neutral according to patterns of low-dose aspirin use, including prediagnosis use or established mortality predictors.Conclusions
Low-dose aspirin use did not reduce mortality among ovarian cancer patients.
SUBMITTER: Verdoodt F
PROVIDER: S-EPMC5830597 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature
Publications
Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study.
British journal of cancer 20180109 4
<h4>Background</h4>Increasing data suggest that aspirin use may improve cancer survival; however, the evidence is sparse for ovarian cancer.<h4>Methods</h4>We examined the association between postdiagnosis use of low-dose aspirin and mortality in a nationwide cohort of women with epithelial ovarian cancer between 2000 and 2012. Information on filled prescriptions of low-dose aspirin, dates and causes of death, and potential confounding factors was obtained from nationwide Danish registries. We u ...[more]